The Gross Margin of Generex Biotechnology Corp (GNBT) is 78.21%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2020-07-31 | 78.21% |
2019-07-31 | 33.29% |
2018-07-31 | 66.67% |
2017-07-31 | 44.83% |